- Press Releases

Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19

SHANGHAI, China, Sept. 19, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for etesevimab (JS016/LY-CoV016) 1,400 mg and bamlanivimab (LY-CoV555) […]

- General

Laos logs 371 new cases of Covid-19

Laos has posted 371 new cases of Covid-19 over the past 24 hours including 303 local transmissions with 225 in Vientiane, according to the National Taskforce Committee for Covid-19 Prevention and Control.Some 68 imported cases were recorded including 1…